177 related articles for article (PubMed ID: 35799892)
1. LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.
Chen W; Liu Y; Kang S; Lv X; Fu W; Zhang J; Song C
Oxid Med Cell Longev; 2022; 2022():5215748. PubMed ID: 35799892
[TBL] [Abstract][Full Text] [Related]
2. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
3. RBM8A Depletion Decreases the Cisplatin Resistance and Represses the Proliferation and Metastasis of Breast Cancer Cells via AKT/mTOR Pathway.
Song T; Zhang H
Breast J; 2022; 2022():4576789. PubMed ID: 36105365
[TBL] [Abstract][Full Text] [Related]
4. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
5. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
[TBL] [Abstract][Full Text] [Related]
6. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
8. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
9. MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway.
Li Z; Li C; Wu Q; Tu Y; Wang C; Yu X; Li B; Wang Z; Sun S; Sun S
Cell Death Dis; 2021 Jan; 12(1):97. PubMed ID: 33462219
[TBL] [Abstract][Full Text] [Related]
10. Retracted: LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9864513. PubMed ID: 38189021
[TBL] [Abstract][Full Text] [Related]
11. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
Li Z; Jin Q; Sun Y
J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
[TBL] [Abstract][Full Text] [Related]
12. ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway.
Qiu H; Zhang L; Wang D; Zhang Y; Cai H; Miao H; Chu F
Comput Math Methods Med; 2022; 2022():4622877. PubMed ID: 35111235
[TBL] [Abstract][Full Text] [Related]
13. Nesfatin-1 Promotes Proliferation, Migration and Invasion of HTR-8/SVneo Trophoblast Cells and Inhibits Oxidative Stress via Activation of PI3K/AKT/mTOR and AKT/GSK3β Pathway.
Li T; Wei S; Fan C; Tang D; Luo D
Reprod Sci; 2021 Feb; 28(2):550-561. PubMed ID: 32974855
[TBL] [Abstract][Full Text] [Related]
14. The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling.
Zhan CH; Ding DS; Zhang W; Wang HL; Mao ZY; Liu GJ
Bioengineered; 2022 Apr; 13(4):8478-8489. PubMed ID: 35322748
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway.
Song Q; Zhang W; Shi D; Zhang Z; Zhao Q; Wang M; Huang M; Meng J; Cui W; Luo X
Cancer Med; 2023 Jun; 12(12):13538-13550. PubMed ID: 37220224
[TBL] [Abstract][Full Text] [Related]
16. LINC00960 regulates cell proliferation and glycolysis in pancreatic cancer through the miR-326-3p/TUFT1/AKT-mTOR axis.
Zhou B; Lei JH; Wang Q; Qu TF; Cha LC; Zhan HX; Liu SL; Hu X; Sun CD; Cao JY; Qiu FB; Guo WD
Kaohsiung J Med Sci; 2022 Dec; 38(12):1155-1167. PubMed ID: 36149758
[TBL] [Abstract][Full Text] [Related]
17. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
Chi F; Chen L; Jin X; He G; Liu Z; Han S
Exp Cell Res; 2022 Mar; 412(2):113035. PubMed ID: 35065924
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer.
Shinde A; Wilmanski T; Chen H; Teegarden D; Wendt MK
Breast Cancer Res; 2018 Jul; 20(1):76. PubMed ID: 30005601
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.
Guo Y; Feng L
Arch Biochem Biophys; 2022 Oct; 729():109381. PubMed ID: 36027936
[TBL] [Abstract][Full Text] [Related]
20. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
